Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3631)
All Articles published online
|
Oct 14, 2010 (publication date) through Apr 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 2010; 16(38): 4784-4791 [PMID: 20939106 DOI: 10.3748/wjg.v16.i38.4784] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i38/4784.htm |
| Number | Citing Articles |
| 1 |
Cassiano Pozzati, Wellington Martins. [Diagnostic aspects of non alcoholic fatty liver disease] Aspectos diagnósticos da esteatose hepática não alcóolica. Experts in Ultrasound: Reviews and Perspectives 2011; 3(2): 54 doi: 10.4281/eurp.2011.02.05
|
| 2 |
Iradj Maleki, Mahmood Reza Aminafshari, Tarang Taghvaei, Vahid Hosseini, Alireza Rafiei, Zhila Torabizadeh, Maryam Barzin, Elahe Orang. Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(35): 12566-12573 doi: 10.3748/wjg.v20.i35.12566
|
| 3 |
Llorenç Caballería Rovira, Irfan Majeed, Alba Martínez Escudé, Ingrid Arteaga Pillasagua, Pere Torán Monserrat. Esteatosis hepática: diagnóstico y seguimiento. FMC - Formación Médica Continuada en Atención Primaria 2017; 24(7): 378 doi: 10.1016/j.fmc.2017.03.001
|
| 4 |
Fulvio Cacciapuoti, Anna Scognamiglio, Rossella Palumbo, Raffaele Forte, Federico Cacciapuoti. Silymarin in non alcoholic fatty liver disease. World Journal of Hepatology 2013; 5(3): 109-113 doi: 10.4254/wjh.v5.i3.109
|
| 5 |
Ahmed O. Almobarak, Salma Barakat, Eltayeb A. Suliman, Wadie M. Elmadhoun, Nabeel A. Mohamed, Israa O. Abobaker, Sufian K. Noor, Sarra O. Bushara, Mohamed H. Ahmed. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?. Arab Journal of Gastroenterology 2015; 16(2): 54 doi: 10.1016/j.ajg.2015.06.001
|
| 6 |
Tamara Milovanovic Alempijevic, Milica Stojkovic Lalosevic, Igor Dumic, Nevena Jocic, Aleksandra Pavlovic Markovic, Sanja Dragasevic, Ivana Jovicic, Snezana Lukic, Dragan Popovic, Tomica Milosavljevic. Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients. Canadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/6070135
|
| 7 |
Ciarán P Fisher, Andrzej M Kierzek, Nick J Plant, J Bernadette Moore. Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(41): 15070-15078 doi: 10.3748/wjg.v20.i41.15070
|
| 8 |
Andrea Boccatonda, Lorenza Del Cane, Lara Marola, Damiano D’Ardes, Gianfranco Lessiani, Nicoletta di Gregorio, Claudio Ferri, Francesco Cipollone, Carla Serra, Francesca Santilli, Fabio Piscaglia. Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. Life 2024; 14(4): 473 doi: 10.3390/life14040473
|
| 9 |
Julie Massart, Karima Begriche, Anne Corlu, Bernard Fromenty. Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(3): 1062 doi: 10.3390/ijms23031062
|
| 10 |
Mariana V. Machado, Helena Cortez-Pinto. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. Journal of Hepatology 2013; 58(5): 1007 doi: 10.1016/j.jhep.2012.11.021
|
| 11 |
Li‐Kun Zhong, Guo Zhang, Shuang‐Yan Luo, Wu Yin, Huai‐Yu Song. The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B. Journal of Clinical Laboratory Analysis 2020; 34(7) doi: 10.1002/jcla.23270
|
| 12 |
Pirjo Käkelä, Tuomo Rantanen, Hannu Paajanen, Kirsi A Virtanen. Fatal complications after an interrupted gastric bypass operation in a patient with non-alcoholic fatty liver disease and massive obesity: a case report. Journal of Surgical Case Reports 2021; 2021(6) doi: 10.1093/jscr/rjab247
|
| 13 |
Silvia I. Mora, Jonathan García-Román, Iván Gómez-Ñañez, Rebeca García-Román. Chronic liver diseases and the potential use of S-adenosyl-l-methionine as a hepatoprotector. European Journal of Gastroenterology & Hepatology 2018; 30(8): 893 doi: 10.1097/MEG.0000000000001141
|
| 14 |
Josué Gilberto Gudiel Lemus. Hígado Graso no Alcohólico en mujeres. Revista de Postgrados de Medicina 2022; 1(2): 32 doi: 10.62267/rev.post.med.v1i2.17
|
| 15 |
Mehran Rahimlou, Hoda Ahmadnia, Azita Hekmatdoost. Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future. World Journal of Hepatology 2015; 7(25): 2597-2602 doi: 10.4254/wjh.v7.i25.2597
|
| 16 |
Mona Hegazy, Soheir Abo-Elfadl, Abeer Mostafa, Magdy Ibrahim, Laila Rashed, Ahmed Salman. Serum Resistin Level and Its Receptor Gene Expression in
Liver Biopsy as Predictors for the Severity of
Nonalcoholic Fatty Liver Disease. Euroasian Journal of Hepato-Gastroenterology 2014; 4(2): 59 doi: 10.5005/jp-journals-10018-1102
|
| 17 |
Anastasia Asimakopoulou, Ralf Weiskirchen. Lipocalin 2 in the pathogenesis of fatty liver disease and nonalcoholic steatohepatitis. Clinical Lipidology 2015; 10(1): 47 doi: 10.2217/clp.14.65
|
| 18 |
Yong Jiang, Tao Han, Zhi-Guang Zhang, Ying Zhang, Feng-Xiang Qi. Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis. Revista Española de Enfermedades Digestivas 2017; 110 doi: 10.17235/reed.2017.4690/2016
|
| 19 |
Zhangrui Cheng, Conrad Ferris, Mark A. Crowe, Klaus L. Ingvartsen, Clément Grelet, Amélie Vanlierde, Leslie Foldager, Frank Becker, D. Claire Wathes. Hepatic Global Transcriptomic Profiles of Holstein Cows According to Parity Reveal Age-Related Changes in Early Lactation. International Journal of Molecular Sciences 2023; 24(12): 9906 doi: 10.3390/ijms24129906
|
| 20 |
Sabine Siegert, Zhonghao Yu, Rui Wang-Sattler, Thomas Illig, Jerzy Adamski, Jochen Hampe, Susanna Nikolaus, Stefan Schreiber, Michael Krawczak, Michael Nothnagel, Ute Nöthlings, Erica Villa. Diagnosing Fatty Liver Disease: A Comparative Evaluation of Metabolic Markers, Phenotypes, Genotypes and Established Biomarkers. PLoS ONE 2013; 8(10): e76813 doi: 10.1371/journal.pone.0076813
|
| 21 |
Su-Mei Li, Guang-Xia Li, Dong-Mei Fu, Yu Wang, Li-Qun Dang. Liver fibrosis evaluation by ARFI and APRI in chronic hepatitis C. World Journal of Gastroenterology 2014; 20(28): 9528-9533 doi: 10.3748/wjg.v20.i28.9528
|
| 22 |
Xing-Xi Gao, Da-Hua Shi, Yun-Xi Chen, Jiang-Tao Cui, Yu-Rong Wang, Chun-Ping Jiang, Jun-Hua Wu. The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation. Archives of Pharmacal Research 2012; 35(8): 1479 doi: 10.1007/s12272-012-0819-y
|
| 23 |
Dongsub Jeon, Minkook Son, Juhyun Shim. Dynamics of Serum Retinol and Alpha-Tocopherol Levels According to Non-Alcoholic Fatty Liver Disease Status. Nutrients 2021; 13(5): 1720 doi: 10.3390/nu13051720
|
| 24 |
Dimitrios G Bouzianas, Stella D Bouziana, Apostolos I Hatzitolios. Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids. Nutrition Reviews 2013; 71(11): 753 doi: 10.1111/nure.12073
|
| 25 |
John Richard, Ildiko Lingvay. Hepatic steatosis and Type 2 diabetes: current and future treatment considerations. Expert Review of Cardiovascular Therapy 2011; 9(3): 321 doi: 10.1586/erc.11.15
|
| 26 |
Y.H. Yen, F.Y. Kuo, C.C. Lin, C.L. Chen, K.C. Chang, M.C. Tsai, T.H. Hu. Predicting Hepatic Steatosis in Living Liver Donors Via Controlled Attenuation Parameter. Transplantation Proceedings 2018; 50(10): 3533 doi: 10.1016/j.transproceed.2018.06.039
|
| 27 |
Rodrigo Bremer Nones, Cláudia Pontes Ivantes, Maria Lucia Alves Pedroso. Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?. Archives of Endocrinology and Metabolism 2017; 61(3): 276 doi: 10.1590/2359-3997000000233
|
| 28 |
Bruna Z. Schild, Luciano Neto Santos, Márcia Keller Alves. Nonalcoholic fatty liver disease and its association with metabolic syndrome in the preoperative period in patients undergoing bariatric surgery. Revista da Associação Médica Brasileira (English Edition) 2013; 59(2): 155 doi: 10.1016/S2255-4823(13)70449-1
|
| 29 |
Mohsen Razavizade, Raika Jamali, Abbas Arj, Hamidreza Talari. Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International 2012; 11(5): 513 doi: 10.1016/S1499-3872(12)60216-1
|
| 30 |
Álvaro Terán Lantarón, Javier Crespo García. Cribado de la enfermedad hepática por depósito de grasa: cómo y a quién. Gastroenterología y Hepatología 2011; 34(4): 278 doi: 10.1016/j.gastrohep.2010.11.010
|
| 31 |
S. A. Pavlovskyi. EVALUATION OF CONTENT OF CITOKINS IN PATIENTS� BLOOD WITH NON-ALCOHOLIC STEATOHEPATITIS COMBINED WITH DIABETES MELLITUS TYPE 2 UNDER THE INFLUENCE OF COMBINED SUCTIONAL THERAPY. Bulletin of Problems Biology and Medicine 2018; (144): 170 doi: 10.29254/2077-4214-2018-1-2-143-170-175
|
| 32 |
Llorenç Caballería, Joan Saló, Annalisa Berzigotti, Ramón Planas, Carme Vila, Carlos Huertas, Miquel Torres, Pere Torán, Joan Caballería. Hígado graso no alcohólico. Documento de posicionamiento de la Societat Catalana de Digestologia. Gastroenterología y Hepatología 2014; 37(6): 372 doi: 10.1016/j.gastrohep.2014.03.005
|
| 33 |
Earl Kim, Yunkoo Kang, Seungmin Hahn, Mi Jung Lee, Young Nyun Park, Hong Koh. The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice. Korean Journal of Pediatrics 2013; 56(1): 19 doi: 10.3345/kjp.2013.56.1.19
|
| 34 |
A. L. Kalinin, E. V. Tsitko, E. N. Snitsarenko, T. V. Hvatik. NONINVASIVE DIAGNOSTICS OF NON-ALCOHOLIC STEATOHEPATITIS. Health and Ecology Issues 2011; (1): 95 doi: 10.51523/2708-6011.2011-8-1-18
|
| 35 |
Amir H. Davarpanah, Jeffrey C. Weinreb. The Role of Imaging in Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 2013; 47(Supplement 1): S7 doi: 10.1097/MCG.0b013e31827f0d3d
|
| 36 |
Isabel C. Hernández-Osorio, Marco Antonio Luján-Ramos. Aspectos relevantes de la enfermedad por hígado graso no alcohólico. Hepatología 2021; : 310 doi: 10.52784/27112330.137
|
| 37 |
Paolo Ricchi, Antonella Meloni, Silvia Costantini, Anna Spasiano, Tiziana Di Matola, Alessia Pepe, Patrizia Cinque, Aldo Filosa. Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia. Annals of Hematology 2017; 96(9): 1541 doi: 10.1007/s00277-017-3057-z
|
| 38 |
Yi-Lin Ma, Jiang-Feng Ke, Jun-Wei Wang, Yu-Jie Wang, Man-Rong Xu, Lian-Xi Li. Blood lactate levels are associated with an increased risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: a real-world study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1133991
|
| 39 |
Tannaz Eslamparast, Sareh Eghtesad, Hossein Poustchi, Azita Hekmatdoost. Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. World Journal of Hepatology 2015; 7(2): 204-212 doi: 10.4254/wjh.v7.i2.204
|
| 40 |
Maria Franzini, Irene Fornaciari, Vanna Fierabracci, Hassan Aziz Elawadi, Valeria Bolognesi, Simona Maltinti, Angelo Ricchiuti, Nicola De Bortoli, Santino Marchi, Alfonso Pompella, Claudio Passino, Michele Emdin, Aldo Paolicchi. Accuracy of b‐GGT fraction for the diagnosis of non‐alcoholic fatty liver disease. Liver International 2012; 32(4): 629 doi: 10.1111/j.1478-3231.2011.02673.x
|
| 41 |
D. A. Miles, C. S. Levi, J. Uhanova, S. Cuvelier, K. Hawkins, G. Y. Minuk. Pocket-Sized Versus Conventional Ultrasound for Detecting Fatty Infiltration of the Liver. Digestive Diseases and Sciences 2020; 65(1): 82 doi: 10.1007/s10620-019-05752-x
|
| 42 |
Geum-Youn Gwak. Diagnosis of Non-alcoholic Fatty Liver Disease. The Journal of Korean Diabetes 2014; 15(2): 82 doi: 10.4093/jkd.2014.15.2.82
|
| 43 |
Nitin Kapoor, Sanjay Kalra. Metabolic-Associated Fatty Liver Disease and Diabetes. Endocrinology and Metabolism Clinics of North America 2023; 52(3): 469 doi: 10.1016/j.ecl.2023.02.006
|
| 44 |
Süleyman GÜNAY, Zehra Betül PAKÖZ, Haydar ADANIR. Evaluation of C-reactive protein levels in the differentiation of non-alcoholic steatohepatitis and simple liver steatosis. Akdeniz Medical Journal 2022; : 202 doi: 10.53394/akd.976570
|
| 45 |
Bruna Z. Schild, Luciano Neto Santos, Márcia Keller Alves. Doença hepática gordurosa não alcoólica e sua relação com a síndrome metabólica no pré-operatório de pacientes submetidos à cirurgia bariátrica. Revista da Associação Médica Brasileira 2013; 59(2): 155 doi: 10.1016/j.ramb.2012.10.004
|
| 46 |
Kai-Lun Shih, Wei-Wen Su, Chia-Chu Chang, Chew-Teng Kor, Chen-Te Chou, Ting-Yu Chen, Hung-Ming Wu. Comparisons of parallel potential biomarkers of 1H-MRS-measured hepatic lipid content in patients with non-alcoholic fatty liver disease. Scientific Reports 2016; 6(1) doi: 10.1038/srep24031
|
| 47 |
Maëna Le Corvec, Coralie Allain, Salim Lardjane, Thibault Cavey, Bruno Turlin, Alain Fautrel, Karima Begriche, Valérie Monbet, Bernard Fromenty, Patricia Leroyer, Pascal Guggenbuhl, Martine Ropert, Olivier Sire, Olivier Loréal. Mid-infrared fibre evanescent wave spectroscopy of serum allows fingerprinting of the hepatic metabolic status in mice. The Analyst 2016; 141(22): 6259 doi: 10.1039/C6AN00136J
|
| 48 |
Nitin Kapoor, Jennifer Audsley, Priscilla Rupali, Joe Sasadeusz, Thomas V. Paul, Nihal Thomas, Sharon R. Lewin. A gathering storm. AIDS 2019; 33(7): 1105 doi: 10.1097/QAD.0000000000002161
|
| 49 |
Anastasia Asimakopoulou, Sabine Weiskirchen, Ralf Weiskirchen. Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy. Frontiers in Physiology 2016; 7 doi: 10.3389/fphys.2016.00430
|
| 50 |
Shouxing Yang, Jing Xu. Elevated small dense low‐density lipoprotein cholesterol to high‐density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction associated fatty liver disease in Chinese patients with type 2 diabetes mellitus. Journal of Diabetes Investigation 2024; doi: 10.1111/jdi.14148
|